Skip to main content
Sacral Nerve Stimulation Market by Product, End-user, and Geography - Forecast and Analysis 2020-2024

Sacral Nerve Stimulation Market by Product, End-user, and Geography - Forecast and Analysis 2020-2024

Published: Dec 2020 120 Pages SKU: IRTNTR44633

The sacral nerve stimulation (SNS) market size has the potential to grow by USD 192.50 million during 2020-2024, and the market’s growth momentum will accelerate during the forecast period.

This report provides a detailed analysis of the market by product (implantable SNS devices and external SNS devices), end-user (hospitals and ASCs), and geography (APAC, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Abbott Laboratories, Axonics Modulation Technologies Inc., Boston Scientific Corp., Laborie Medical Technologies Corp., LivaNova Plc, Medtronic Plc, NeuroPace Inc., Nevro Corp., Nuvectra Corp., and Synapse Biomedical Inc.

Market Overview

Browse TOC and LoE with selected illustrations and example pages of Sacral Nerve Stimulation Market

Request a FREE sample now!

Market Competitive Analysis

The SNS market is concentrated. Abbott Laboratories, Axonics Modulation Technologies Inc., and Boston Scientific Corp. are some of the major market participants. Factors such as increasing geriatric population with sacral nerve issues, increasing R&D efforts by companies in the SNS market, and untapped emerging countries for SNS adoption will offer immense growth opportunities. However, side-effects concerned with the use of SNS devices, magnetic sphincter augmentation posing a threat to SNS in treating severe fecal incontinence, and unfavorable reimbursement scenario for SNS procedures may impede market growth. To make the most of the opportunities, vendors should focus on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this sacral nerve stimulation market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this sacral nerve stimulation market analysis report provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading companies, including:

  • Abbott Laboratories
  • Axonics Modulation Technologies Inc.
  • Boston Scientific Corp.
  • Laborie Medical Technologies Corp.
  • LivaNova Plc
  • Medtronic Plc
  • NeuroPace Inc.
  • Nevro Corp.
  • Nuvectra Corp.
  • Synapse Biomedical Inc.

 

Sacral Nerve Stimulation Market: Segmentation by Geography

For more insights on the market share of various regions Request for a FREE sample now!

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. North America will offer several growth opportunities to market vendors during the forecast period. 

35% of the market’s growth will originate from North America during the forecast period. The US is a key market for sacral nerve stimulation in North America. This report provides an accurate prediction of the contribution of all segments to the growth of the sacral nerve stimulation market size.

Sacral Nerve Stimulation Market: Key Highlights of the Report for 2020-2024

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will drive sacral nerve stimulation market growth during the next five years
  • Precise estimation of the SNS market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the sacral nerve stimulation industry across APAC, Europe, North America, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of sacral nerve stimulation market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

You may be interested in: 

Peripheral Nerve Stimulators Market - The market size has the potential to grow by USD 141.03 million during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 5.25%. 

Sacral Nerve Stimulation Market Scope

Report Coverage

Details

Page number

120

Base year

2019

Forecast period

2020-2024

Growth momentum & CAGR

Accelerate at a CAGR of 5%

Market growth 2020-2024

$ 192.50 million

Market structure

Concentrated

YoY growth (%)

1.99

Regional analysis

North America, Europe, APAC, and ROW

Performing market contribution

North America at 35%

Key consumer countries

US, UK, Germany, China, Japan, and France

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, Axonics Modulation Technologies Inc., Boston Scientific Corp., Laborie Medical Technologies Corp., LivaNova Plc, Medtronic Plc, NeuroPace Inc., Nevro Corp., Nuvectra Corp., and Synapse Biomedical Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Sacral Nerve Stimulation market growth will increase by 192.50 million during 2019-2024.

The Sacral Nerve Stimulation market is expected to grow at a CAGR of 5.27% during 2019-2024.

Sacral Nerve Stimulation market is segmented by Product( Implantable SNS devices, External SNS devices) Geographic( North America, Europe, APAC, ROW)

Abbott Laboratories, Axonics Modulation Technologies Inc., Boston Scientific Corp., Laborie Medical Technologies Corp., LivaNova Plc, Medtronic Plc, NeuroPace Inc., Nevro Corp., Nuvectra Corp., Synapse Biomedical Inc. are a few of the key vendors in the Sacral Nerve Stimulation market.

North America will register the highest growth rate of 34.86% among the other regions. Therefore, the Sacral Nerve Stimulation market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, UK, Germany, China, Japan, France

  • Increasing geriatric population with sacral nerve issues is the driving factor this market.

The Sacral Nerve Stimulation market vendors should focus on grabbing business opportunities from the Implantable SNS devices segment as it accounted for the largest market share in the base year.